{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:01:26Z","timestamp":1791892886599,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd013745","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000}}],"reference-count":91,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013745.pub2","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:04:36Z","timestamp":1740380676000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Non-vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta-analysis"],"prefix":"10.1002","volume":"2025","author":[{"given":"Samer","family":"Al Said","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology; University Heart Center Freiburg Bad Krozingen, Medical Center \u2013 University of Freiburg, Faculty of Medicine, University of Freiburg; Freiburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Kaier","sequence":"additional","affiliation":[{"name":"Institute for Medical Biometry and Statistics; Faculty of Medicine and Medical Center, University of Freiburg; Freiburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edris","family":"Nury","sequence":"additional","affiliation":[{"name":"Institute for Evidence in Medicine, Medical Center \u2013 University of Freiburg; Faculty of Medicine, University of Freiburg; Freiburg Germany"},{"name":"Department of General Practice and Primary Care; University Medical Center Hamburg-Eppendorf; Hamburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima","family":"Alsaid","sequence":"additional","affiliation":[{"name":"Institute for Evidence in Medicine, Medical Center \u2013 University of Freiburg; Faculty of Medicine, University of Freiburg; Freiburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Michael","family":"Gibson","sequence":"additional","affiliation":[{"name":"Cardiology Division, Beth Israel Deaconess Medical Center; Harvard Medical School; Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Bax","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Leiden University Medical Center; Leiden Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Westermann","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology; University Heart Center Freiburg Bad Krozingen, Medical Center \u2013 University of Freiburg, Faculty of Medicine, University of Freiburg; Freiburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg J","family":"Meerpohl","sequence":"additional","affiliation":[{"name":"Institute for Evidence in Medicine; Medical Center \u2013 University of Freiburg, Faculty of Medicine, University of Freiburg; Freiburg Germany"},{"name":"Cochrane Germany; Cochrane Germany Foundation; Freiburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"10.1002\/14651858.CD013745.pub2-BIB0001|cit1","unstructured":"Anticoagulant versus dual antiplatelet therapy for preventing leaflet thrombosis and cerebral embolization after transcatheter aortic valve replacement (ADAPT-TAVR) https:\/\/clinicaltrials.gov\/show\/NCT03284827 2017"},{"issue":"6","key":"10.1002\/14651858.CD013745.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.122.059512","article-title":"Edoxaban versus dual antiplatelet therapy for leaflet thrombosis and cerebral thromboembolism after TAVR: the ADAPT-TAVR randomized clinical trial","volume":"146","author":"Park","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD013745.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"e042587","DOI":"10.1136\/bmjopen-2020-042587","article-title":"Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement","volume":"11","author":"Park","year":"2021","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ahj.2018.03.008","article-title":"Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: The randomized ATLANTIS trial","volume":"200","author":"Collet","year":"2018","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0005|cit5","doi-asserted-by":"crossref","unstructured":"Collet JP Van Belle E Thiele H Berti S Lhermusier T Manigold T ATLANTIS Investigators of the ACTION Group Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial European Heart Journal 2022 43 29 2783 97 10.1093\/eurheartj\/ehac242","DOI":"10.1093\/eurheartj\/ehac408"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0006|cit6","unstructured":"Anti-thrombotic strategy to lower all cardiovascular and neurologic ischemic and hemorrhagic events after trans-aortic valve implantation for aortic stenosis: the ATLANTIS trial https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2015%E2%80%90001676%E2%80%9021%E2%80%90ES"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0007|cit7","unstructured":"Anti-thrombotic strategy after trans-aortic valve implantation for aortic stenosis (ATLANTIS) https:\/\/clinicaltrials.gov\/show\/NCT02664649"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0008|cit8","unstructured":"Edoxaban Versus Standard of Care and Their Effects on Clinical Outcomes in Patients Having Undergone Transcatheter Aortic Valve Implantation \u2013 In Atrial Fibrillation (ENVISAGE-TAVI AF) https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=2016-003930-26."},{"key":"10.1002\/14651858.CD013745.pub2-BIB0009|cit9","unstructured":"Edoxaban versus standard of care and their effects on clinical outcomes in patients having undergone TAVI - in atrial fibrillation https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=JPRN-jRCTs031180144"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0010|cit10","unstructured":"Edoxaban compared to standard care after heart valve replacement using a catheter in patients with atrial fibrillation (ENVISAGE-TAVI AF) https:\/\/clinicaltrials.gov\/show\/NCT02943785"},{"issue":"18 Supplement 1","key":"10.1002\/14651858.CD013745.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"B163","DOI":"10.1016\/j.jacc.2017.09.495","article-title":"Edoxaban versus standard of care and their effects on clinical outcomes in patients having undergone transcatheter aortic valve implantation in atrial fibrillation - rationale and design of the ENVISAGE-TAVI AF trial","volume":"70","author":"Van Mieghem","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"issue":"23","key":"10.1002\/14651858.CD013745.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1056\/NEJMoa2111016","article-title":"Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR","volume":"385","author":"Van Mieghem","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ahj.2018.07.006","article-title":"Edoxaban versus standard of care and their effects on clinical outcomes in patients having undergone transcatheter aortic valve implantation in atrial fibrillation - rationale and design of the ENVISAGE-TAVI AF trial","volume":"205","author":"Van Mieghem","year":"2018","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0014|cit14","unstructured":"Comparison of a rivaroxaban-based strategy with an antiplatelet-based strategy following successful TAVR for the prevention of leaflet thickening and reduced leaflet motion as evaluated by four-dimensional, volume-rendered computed tomography (4DCT) https:\/\/clinicaltrials.gov\/show\/NCT02833948"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0015|cit15","unstructured":"Global multicenter, open-label, randomized, event-driven, active-controlled study comparing a rivAroxaban-based antithrombotic strategy to an antipLatelet-based strategy after transcatheter aortIc vaLve rEplacement (TAVR) to Optimize clinical outcomes https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=DRKS00010225"},{"issue":"2","key":"10.1002\/14651858.CD013745.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1911425","article-title":"A controlled trial of rivaroxaban after transcatheter aortic-valve replacement","volume":"382","author":"Dangas","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"25","key":"10.1002\/14651858.CD013745.pub2-BIB0017|cit17","first-page":"E1005","article-title":"Randomized clinical trial comparing a rivaroxaban-based strategy with an antiplatelet-based strategy for the prevention of subclinical leaflet thrombosis in transcatheter aortic valves (GALILEO-4D)","volume":"140","author":"De Backer","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD013745.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1056\/NEJMoa1911426","article-title":"Reduced leaflet motion after transcatheter aortic-valve replacement","volume":"382","author":"De Backer","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0019|cit19","unstructured":"A study to compare rivaroxaban, following successful TAVR, to an antiplatelet drug and determine if it is superior in reducing death or first thromboembolic events (DTE) and non-inferior towards primary bleeding events (PBE) https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=2015-001975-30"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0020|cit20","doi-asserted-by":"crossref","unstructured":"Froehlich GM Falk V Endres M Stangl V Woehrle J Steinbeck L Randomized clinical trial comparing a rivaroxaban-based with an antiplatelet-based strategy for cerebral embolization after TAVR (EARTH TAVR)-a magnetic resonance imaging substudy of the GALILEO trial European Heart Journal 2020 41 (Supplement_2) 2623","DOI":"10.1093\/ehjci\/ehaa946.2623"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0021|cit21","doi-asserted-by":"crossref","unstructured":"Giustino G Tijssen J Windecker S Dangas G Rivaroxaban after transcatheter aortic valve replacement: the GALILEO trial Cardiovascular Research 2020 116 3 E39-E41","DOI":"10.1093\/cvr\/cvaa026"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0022|cit22","unstructured":"Global study comparing a rivaroxaban-based antithrombotic strategy to an antiplatelet-based strategy after transcatheter aortic valve replacement to optimize clinical outcomes https:\/\/clinicaltrials.gov\/show\/NCT02556203"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ahj.2016.10.017","article-title":"Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study","volume":"184","author":"Windecker","year":"2017","journal-title":"American Heart Journal"},{"issue":"15","key":"10.1002\/14651858.CD013745.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jcin.2021.05.025","article-title":"TAVR patients requiring anticoagulation: direct oral anticoagulant or vitamin K antagonist?","volume":"14","author":"Didier","year":"2021","journal-title":"JACC. Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0025|cit25","unstructured":"The nordic aortic valve intervention trial 4 (NOTION-4) https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2020-003361-19-DK 2020"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD013745.pub2-BIB0026|cit26","first-page":"429","article-title":"Type of oral anticoagulants and outcomes after transcatheter aortic valve implantation","volume":"39","author":"Jochheim","year":"2018","journal-title":"European Heart Journal"},{"issue":"16","key":"10.1002\/14651858.CD013745.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jcin.2019.03.003","article-title":"Oral anticoagulant type and outcomes after transcatheter aortic valve replacement","volume":"12","author":"Jochheim","year":"2019","journal-title":"JACC. Cardiovascular Interventions"},{"issue":"22","key":"10.1002\/14651858.CD013745.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.jcin.2020.09.013","article-title":"Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after TAVR","volume":"13","author":"Kawashima","year":"2020","journal-title":"JACC. Cardiovascular Interventions"},{"issue":"7","key":"10.1002\/14651858.CD013745.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.amjcard.2018.12.042","article-title":"Continued versus interrupted oral anticoagulation during transfemoral transcatheter aortic valve implantation and impact of postoperative anticoagulant management on outcome in patients with atrial fibrillation","volume":"123","author":"Mangner","year":"2019","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0030|cit30","unstructured":"Anticoagulation alone versus anticoagulation and aspirin following transcatheter aortic valve interventions (1:1) https:\/\/clinicaltrials.gov\/study\/NCT02735902"},{"issue":"1","key":"10.1002\/14651858.CD013745.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcin.2016.10.023","article-title":"Apixaban in patients with atrial fibrillation after transfemoral aortic valve replacement","volume":"10","author":"Seeger","year":"2017","journal-title":"JACC. Cardiovascular Interventions"},{"issue":"18 Supplement 1","key":"10.1002\/14651858.CD013745.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"B53","DOI":"10.1016\/j.jacc.2017.09.177","article-title":"Short term TAVR outcome in patients with indication for oral anticoagulation","volume":"70","author":"Woitek","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0033|cit33","unstructured":"Anticoagulation versus acetylsalicylic acid after transcatheter aortic valve implantation (ACASA-TAVI) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05035277"},{"issue":"16","key":"10.1002\/14651858.CD013745.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.jcin.2016.06.025","article-title":"Warfarin and antiplatelet therapy versus warfarin alone for treating patients with atrial fibrillation undergoing transcatheter aortic valve replacement","volume":"22","author":"Abdul-Jawad Altisent","year":"2016","journal-title":"JACC Cardiovascular Interventions"},{"issue":"4","key":"10.1002\/14651858.CD013745.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1055\/s-0038-1673412","article-title":"Anticoagulation in atherosclerotic disease","volume":"38","author":"Al Said","year":"2018","journal-title":"Hamostaseologie"},{"issue":"12","key":"10.1002\/14651858.CD013745.pub2-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013252.pub2","article-title":"Non-vitamin K antagonist oral anticoagulants (NOACs) post-percutaneous coronary intervention: a network meta-analysis","author":"Al Said","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013745.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1182\/asheducation-2013.1.464","article-title":"Pros and cons of new oral anticoagulants","volume":"2013","author":"Bauer","year":"2013","journal-title":"Hematology (Amsterdam, Netherlands)"},{"issue":"5","key":"10.1002\/14651858.CD013745.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fcvm.2018.00088","article-title":"Access sites for TAVI: patient selection criteria, technical aspects, and outcomes","volume":"17","author":"Biasco","year":"2018","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jclinepi.2017.10.005","article-title":"Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis","volume":"93","author":"Brignardello-Petersen","year":"2018","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0040|cit40","first-page":"30497","article-title":"GRADE approach to rate the certainty from a network meta-analysis: avoiding spurious judgments of imprecision in sparse networks","volume":"18","author":"Brignardello-Petersen","year":"2018","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ijcard.2016.11.104","article-title":"Evaluation of current practices in transcatheter aortic valve implantation: the WRITTEN (WoRldwIde TAVI ExperieNce) survey","volume":"228","author":"Cerrato","year":"2017","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0042|cit42","doi-asserted-by":"crossref","unstructured":"Chaimani A Caldwell DM Li T Higgins JP Salanti G Chapter 11: Undertaking network meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from training.cochrane.org\/handbook\/archive\/v6","DOI":"10.1002\/9781119536604.ch11"},{"issue":"10","key":"10.1002\/14651858.CD013745.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.jcin.2015.06.010","article-title":"Baseline characteristics and prognostic implications of pre-existing and new-onset atrial fibrillation after transcatheter aortic valve implantation: results from the FRANCE-2 registry","volume":"24;8","author":"Chopard","year":"2015","journal-title":"JACC. Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0044|cit44","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"12","key":"10.1002\/14651858.CD013745.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD013745.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"e003287","DOI":"10.1161\/CIRCOUTCOMES.116.003287","article-title":"Quantifying the shift toward transcatheter aortic valve replacement in low-risk patients: a meta-analysis","volume":"10","author":"De Sciscio","year":"2017","journal-title":"Circulation. Cardiovascular Quality and Outcomes"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0047|cit47","doi-asserted-by":"crossref","unstructured":"Deeks JJ Higgins JP Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from training.cochrane.org\/handbook\/archive\/v6","DOI":"10.1002\/9781119536604"},{"issue":"11","key":"10.1002\/14651858.CD013745.pub2-BIB0048|cit48","first-page":"1218","article-title":"Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves","volume":"4","author":"Eggebrecht","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"issue":"14","key":"10.1002\/14651858.CD013745.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"5","author":"Eikelboom","year":"2017","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev-med-062209-095159","article-title":"Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism","volume":"62","author":"Eriksson","year":"2011","journal-title":"Annual Review of Medicine"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0051|cit51","unstructured":"FDA expands indication for several transcatheter heart valves to patients at low risk for death or major complications associated with open-heart surgery www.fda.gov\/news-events\/press-announcements\/fda-expands-indication-several-transcatheter-heart-valves-patients-low-risk-death-or-major"},{"issue":"22","key":"10.1002\/14651858.CD013745.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0053|cit53","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2023"},{"issue":"11","key":"10.1002\/14651858.CD013745.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013745.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"e007411","DOI":"10.1161\/CIRCINTERVENTIONS.118.007411","article-title":"Antithrombotic therapy after transcatheter aortic valve replacement","volume":"12","author":"Guedeney","year":"2019","journal-title":"Circulation. Cardiovascular Interventions"},{"issue":"24","key":"10.1002\/14651858.CD013745.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1016\/j.jacc.2014.08.052","article-title":"Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement","volume":"64","author":"G\u00e9n\u00e9reux","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0057|cit57","unstructured":"Higgins JP Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0058|cit58","doi-asserted-by":"crossref","unstructured":"Higgins JPT Li T Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from training.cochrane.org\/handbook\/archive\/v6","DOI":"10.1002\/9781119536604"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0059|cit59","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook\/archive\/v6.2"},{"issue":"9_Supplement","key":"10.1002\/14651858.CD013745.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0735-1097(22)01719-3","article-title":"Direct oral anticoagulation therapy in transcatheter aortic valve replacement in patients with concurrent indication for anticoagulation; an updated meta-analysis","volume":"79","author":"Iskandarani","year":"2022","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1002\/sim.5453","article-title":"Quantifying the impact of between-study heterogeneity in multivariate meta-analyses","volume":"31","author":"Jackson","year":"2012","journal-title":"Statistics in Medicine"},{"issue":"5","key":"10.1002\/14651858.CD013745.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1524-4733.2008.00347.x","article-title":"Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons","volume":"11","author":"Jansen","year":"2008","journal-title":"Value in Health"},{"issue":"2","key":"10.1002\/14651858.CD013745.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"e125\u201351","DOI":"10.1161\/CIR.0000000000000665","article-title":"AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation. A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"issue":"15","key":"10.1002\/14651858.CD013745.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jacc.2012.09.001","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document","volume":"60","author":"Kappetein","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2288-13-35","article-title":"A graphical tool for locating inconsistency in network meta-analyses","volume":"13","author":"Krahn","year":"2013","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0066|cit66","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from training.cochrane.org\/handbook\/archive\/v6"},{"issue":"7","key":"10.1002\/14651858.CD013745.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Medicine"},{"issue":"20","key":"10.1002\/14651858.CD013745.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1002\/sim.1875","article-title":"Combination of direct and indirect evidence in mixed treatment comparisons","volume":"23","author":"Lu","year":"2004","journal-title":"Statistics in Medicine"},{"issue":"7181","key":"10.1002\/14651858.CD013745.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nature06797","article-title":"Triggers, targets and treatments for thrombosis","volume":"451","author":"Mackman","year":"2008","journal-title":"Nature"},{"issue":"21","key":"10.1002\/14651858.CD013745.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","article-title":"Ticagrelor with or without aspirin in high-risk patients after PCI","volume":"381","author":"Mehran","year":"2019","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"f2914","DOI":"10.1136\/bmj.f2914","article-title":"Demystifying trial networks and network meta-analysis","volume":"346","author":"Mills","year":"2013","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD013745.pub2-BIB0072|cit72","first-page":"e35","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"issue":"10","key":"10.1002\/14651858.CD013745.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0074|cit74","first-page":"g5630","article-title":"Approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0075|cit75","unstructured":"Efficacy and safety of antithrombotic therapy with non-vitamin K antagonist oral anticoagulants after transcatheter aortic valve replacement: a systematic review and meta-analysis Therapeutic Advances in Chronic Disease 12"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0076|cit76","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"issue":"13","key":"10.1002\/14651858.CD013745.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jcin.2017.04.014","article-title":"Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve: the ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) randomized clinical trial","volume":"10","author":"Rod\u00e9s-Cabau","year":"2017","journal-title":"JACC. Cardiovascular Interventions"},{"issue":"4","key":"10.1002\/14651858.CD013745.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"312\u201324","DOI":"10.1002\/jrsm.1058","article-title":"Network meta-analysis, electrical networks and graph theory","volume":"3","author":"R\u00fccker","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"25","key":"10.1002\/14651858.CD013745.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"4353\u201369","DOI":"10.1002\/sim.6236","article-title":"Reduce dimension or reduce weights? Comparing two approaches to multi-arm studies in network meta-analysis","volume":"33","author":"R\u00fccker","year":"2014","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0081|cit81","unstructured":"R\u00fccker G Schwarzer G Krahn U K\u00f6nig J netmeta: Network Meta-Analysis using Frequentist Methods cran.r\u2013project.org\/web\/packages\/netmeta"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0082|cit82","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from training.cochrane.org\/handbook\/archive\/v6","DOI":"10.1002\/9781119536604.ch15"},{"issue":"14","key":"10.1002\/14651858.CD013745.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1136\/heartjnl-2017-312310","article-title":"New-onset arrhythmias following transcatheter aortic valve implantation: a systematic review and meta-analysis","volume":"104","author":"Siontis","year":"2018","journal-title":"Heart (British Cardiac Society)"},{"issue":"3","key":"10.1002\/14651858.CD013745.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijcard.2014.04.170","article-title":"SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation","volume":"174","author":"Stabile","year":"2014","journal-title":"International Journal Cardiology"},{"issue":"17","key":"10.1002\/14651858.CD013745.pub2-BIB0085|cit85","first-page":"1285","article-title":"Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome","volume":"38","author":"Tarantini","year":"2017","journal-title":"European Heart Journal"},{"issue":"12","key":"10.1002\/14651858.CD013745.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.amjcard.2011.07.049","article-title":"Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation","volume":"108","author":"Ussia","year":"2011","journal-title":"American Journal of Cardiology"},{"issue":"7","key":"10.1002\/14651858.CD013745.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"European Heart Journal"},{"issue":"9_Supplement","key":"10.1002\/14651858.CD013745.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0735-1097(22)01707-7","article-title":"Comparing the efficacy and safety of direct oral anticoagulants and standard of care in patients with atrial fibrillation after successful transcatheter aortic-valve replacement","volume":"79","author":"Vaz","year":"2022","journal-title":"Journal of the American College of Cardiology"},{"issue":"17","key":"10.1002\/14651858.CD013745.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.jcin.2018.05.042","article-title":"Incidence, management, and associated clinical outcomes of new-onset atrial fibrillation following transcatheter aortic valve replacement: an analysis from the STS\/ACC TVT registry","volume":"11","author":"Vora","year":"2018","journal-title":"JACC. Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD013745.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2019.04.018","article-title":"Development of the summary of findings table for network meta-analysis","volume":"115","author":"Yepes-Nunez","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"issue":"10","key":"10.1002\/14651858.CD013745.pub2-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013745","article-title":"Non-vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta-analysis","author":"Al Said","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:32:37Z","timestamp":1786030357000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013745.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":91,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013745.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]}}}